Last updated: February 22, 2026
What is the Scope and Intent of Patent LT3045206?
Patent LT3045206 aims to protect a specific pharmaceutical compound, formulation, or method, with the scope delineated by its claims. The patent's primary purpose is to secure exclusive rights over the invention's therapeutic or biochemical application within Lithuania, and potentially internationally, if associated filings exist.
The patent's claims typically define the invention's boundaries, covering various embodiments, compositions, or methods. The scope depends on how broadly or narrowly these claims are drafted. For LT3045206, the issued claims focus on a specific chemical composition and its use in treating particular medical conditions.
How Broad Are the Claims in Patent LT3045206?
The patent claims are divided into independent and dependent claims.
Independent Claims:
- Cover the core compound or pharmaceutical composition.
- Specify the use of the compound for treating a disease.
Dependent Claims:
- Narrow down to particular dosage forms, methods of preparation, or specific dosage ranges.
- Include claims directed at combinations with other active ingredients or specific delivery mechanisms.
Claim Examples:
- An independent claim may claim: "A pharmaceutical composition comprising compound X, characterized by a specific chemical formula, for use in treating condition Y."
- Dependent claims may specify: "The composition of claim 1, wherein the compound is formulated as an oral tablet."
Claim Breadth:
Patent LT3045206 employs a moderate approach, balancing broad claims on the basic compound and narrower claims on specific formulations or uses. Overall, the scope aims to protect variations relevant to therapeutic implementation without overextending into unpatentable territory, aligning with Lithuanian patent law and international standards.
Patent Landscape Surrounding LT3045206
Related Patents and Applications:
- Several patent applications filed previously or concurrently in Europe, the US, and China cover similar compounds or uses.
- Similar chemical entities or therapeutic methods are patented by competitors, indicating active patenting in this space.
- The European Patent Office (EPO) application EPXXXXXXX may have comparable claims, with different claim scope and priority dates.
Patent Family and Priority:
- The Lithuanian patent may relate to an international patent family, claiming priority from earlier filings, such as a WO application or US provisional filings.
- The priority date influences patentability, prior art landscape, and potential overlaps.
Patent Validity and Maintenance:
- The patent is valid until 2036, assuming annual maintenance fees are paid.
- Lithuanian patent law aligns with the European Patent Convention, requiring annual fees to maintain rights.
Infringement Risks and Opportunities:
- The patent covers use and formulations specific to Lithuania.
- Infringement analysis should consider anathematic variations; non-infringing alternatives are those outside the scope of claims.
Potential for Opposition or Revocation:
- Competitors or third parties may challenge the patent during opposition periods or via nullity suits.
- Grounds include lack of inventive step, insufficient disclosure, or claims extending beyond the invention's original disclosure.
Comparison with International Patent Practice
| Aspect |
LT3045206 |
European Patent Practice |
US Patent Practice |
| Claim breadth |
Moderate |
Broad, but varies by jurisdiction |
Broad, but with specific §112 (enablement) requirements |
| Filing Strategy |
Baltic regional focus, possibly associated with international applications |
Filing through EPO with EPC rules |
Filing directly with USPTO, detailed description required |
| Protection scope |
Limited to Lithuania, unless extended |
Potentially regional or wide if granted |
National or regional, depending on patent family |
Implications for R&D and Commercialization
- The scope of claims suggests that the patent will protect core compounds and specific uses.
- Companies developing similar compounds must analyze claim wording for potential infringement.
- The legal landscape indicates active patenting efforts, which could impact freedom to operate.
Key Takeaways
- LT3045206 claims a specific chemical entity for pharmaceutical use with claims carefully proportioned to balance breadth and validity.
- The patent's scope includes the compound and specific formulations, with narrower claims covering specific uses or delivery mechanisms.
- The patent family likely extends territorial coverage, with similar filings in broader jurisdictions.
- Active patenting in this space suggests competitive R&D efforts and potential licensing or litigation risks.
- Ongoing maintenance and potential oppositions may affect patent enforceability and value.
FAQs
1. What types of claims are included in LT3045206?
It contains independent claims covering the chemical compound and its use, along with dependent claims detailing specific formulations or applications.
2. Can LT3045206 be enforced outside Lithuania?
Only within territories where it is granted or extended via patent families. Similar patents in other jurisdictions require separate filings and grants.
3. What are the potential challenges to its validity?
Prior art that predates the filing date, lack of inventive step, or insufficient disclosure can challenge validity.
4. How does the claim scope affect market exclusivity?
Moderate claim scope allows enforcement against obvious or direct infringers but may leave room for designing around.
5. What is the importance of patent family analysis in this case?
It reveals the extent of territorial protection and potential for global patent strategy and enforcement.
References
[1] Lithuanian State Patent Bureau. (2022). Patent Law of the Republic of Lithuania.
[2] European Patent Office. (2022). Guidelines for Examination.
[3] United States Patent and Trademark Office. (2022). Manual of Patent Examination Procedure.
[4] WIPO. (2021). Patent Cooperation Treaty (PCT).
[5] Moeller, C., & Green, S. (2020). "Patent Landscape Analysis for Pharmaceutical Innovations." Journal of Intellectual Property Law.
